...
首页> 外文期刊>Breast Cancer: Targets and Therapy >Network Pharmacology-Oriented Identification of Key Proteins and Signaling Pathways Targeted by Xihuang Pill in the Treatment of Breast Cancer
【24h】

Network Pharmacology-Oriented Identification of Key Proteins and Signaling Pathways Targeted by Xihuang Pill in the Treatment of Breast Cancer

机译:面向网络药理学鉴定的Xihuang丸靶向乳腺癌的关键蛋白和信号通路

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Purpose:The compound traditional Chinese medicine Xihuang pill (XHP) has been adopted to treat breast cancer (BC) for centuries, but its specific mechanism of action is unclear.Materials and Methods:The active ingredients and related targets of XHP were screened using the TCMSP and TCMID databases. GSE139038 was downloaded from the GEO database, and differentially expressed genes (DEGs) were analyzed. The intersection of targets and DEGs were chosen to build an ingredients-target genes network. Protein-protein interaction network construction and functional enrichment analysis of target genes were conducted.Results:A PPI network of 37 targets was constructed, and seven core nodes (FOS, MYC, JUN, PPARG, MMP9, PTGS2, SERPINE1) were identified. Functional enrichment analysis revealed that the aforementioned targets were mainly enriched in the IL-17, toll-like receptor, and tumor necrosis factor signaling pathways, which are deeply involved in the inflammatory microenvironment of tumors.Conclusion:This network pharmacology study indicated that XHP can inhibit the development of BC by targeting a variety of proteins and signaling pathways involved in the inflammatory microenvironment.? 2020 Wu et al.
机译:目的:复方中国医药犀黄丸(XHP)已经通过治疗乳腺癌(BC)数百年,但其作用的具体机制是unclear.Materials和方法:使用活性成分和XHP的相关指标进行了筛选TCMSP和TCMID数据库。 GSE139038从GEO数据库下载,以及差异表达基因(DEGS)进行了分析。的目标和DEGS的交点被选为建立一个成分 - 靶基因网络。蛋白 - 蛋白相互作用网络的建设和靶基因的功能富集分析是conducted.Results:构建的37个靶甲PPI网络,和七个核心节点(FOS,MYC,JUN,PPARG,MMP9,PTGS2,SERPINE1)进行了鉴定。功能富集分析表明,上述的目标主要富集于IL-17,toll​​样受体,和肿瘤坏死因子信号传导途径,其深入参与tumors.Conclusion的炎症微:此网络药理学研究表明,XHP可以通过靶向多种蛋白质和信令参与炎症的微环境的途径抑制BC的发展。? 2020 Wu等人。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号